Laboratorios Medicamentos Internacionales, S.A. (manufacturing of unpackaged product, primary packaging, secondary packaging, quality control, batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for the symptomatic treatment of allergic rhinitis (seasonal or perennial), chronic idiopathic urticaria, and allergic dermatitis.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage ebastine 10 mg ATC: R06AX22
-
The drug is used for the symptomatic treatment of allergic rhinitis (seasonal or perennial), chronic idiopathic urticaria, and allergic dermatitis.
Dosage form: tablets, dispersible in the oral cavity
Active substance Dosage ebastine 20 mg ATC: R06AX22
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, as well as sudden (urgent) urges to urinate that occur in overactive bladder syndrome.
Dosage form: tablets, film-coated
Active substance Dosage solifenacin 3.8 mg ATC: G04BD08
-
The drug is used for the symptomatic treatment of frequent urination, urinary incontinence, and strong urges to urinate that occur with overactive bladder syndrome.
Dosage form: tablets, film-coated
Active substance Dosage solifenacin 7.5 mg ATC: G04BD08